SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-23-000006
Filing Date
2023-05-09
Accepted
2023-05-09 15:59:39
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20230331.htm   iXBRL 10-Q 733808
2 EX-10.1 ex-101blochseveranceagreem.htm EX-10.1 109817
3 EX-31.1 ex-311q12023.htm EX-31.1 9096
4 EX-32.1 ex-321q12023.htm EX-32.1 4398
  Complete submission text file 0001113148-23-000006.txt   3975749

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20230331.xsd EX-101.SCH 40380
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20230331_cal.xml EX-101.CAL 40076
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20230331_def.xml EX-101.DEF 133631
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20230331_lab.xml EX-101.LAB 418009
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20230331_pre.xml EX-101.PRE 249936
55 EXTRACTED XBRL INSTANCE DOCUMENT infi-20230331_htm.xml XML 458685
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 23901745
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences